Long-term follow-up after intrapleural tPA/DNase therapy for pleural infection

Respirology. 2021 Apr;26(4):388-391. doi: 10.1111/resp.14015. Epub 2021 Feb 15.

Natalia D Popowicz^{1

2

3

4}, Francesco Piccolo⁵, Elaine Yap⁶, Conroy Wong⁶, Ben Brockway⁷, Nicola A Smith⁸, Cameron Sullivan⁶, Arthur W Musk^{1

4}, Y C Gary Lee^{1

2

4}

¹ School of Medicine, University of Western Australia, Perth, WA, Australia.
² Pleural Medicine Research, Institute for Respiratory Health, Perth, WA, Australia.
³ School of Allied Health, University of Western Australia, Perth, WA, Australia.
⁴ Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Perth, WA, Australia.
⁵ Respiratory and Sleep Medicine, St John of God Midland, Perth, WA, Australia.
⁶ Department of Respiratory Medicine, Middlemore Hospital, Auckland, New Zealand.
⁷ Department of Respiratory Medicine, Dunedin Public Hospital, Dunedin, New Zealand.
⁸ Respiratory Department, Wellington Regional Hospital, Wellington, New Zealand.

No abstract available

Keywords: deoxyribonuclease; intrapleural; pleural effusion; respiratory infection; tissue plasminogen activator.

Publication types